Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | |
---|---|---|---|
Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer Journal:Biomolecules | 2022 | ||
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer Journal:International Journal of Molecular Sciences | 2022 | ||
Modulating the Activity of Androgen Receptor for Treating Breast Cancer Journal:International Journal of Molecular Sciences | 2022 | ||
2022 |